Previously, we have shown that in in vitro and ex vivo study (isolated cardiomiocytes and Langendorf perfusion model), administration of doxycycline as MMP-2 and MMP-9 inhibitor protects the heart against consequences of ischemia and reperfusion after acute myocardial infarction [7]. Here, MMP2 is linked to myocardial infarction.